Edition:
United States

Oasmia Pharmaceutical AB (OASM.ST)

OASM.ST on Stockholm Stock Exchange

5.11SEK
12:00pm EDT
Change (% chg)

0.01kr (+0.29%)
Prev Close
5.09kr
Open
5.09kr
Day's High
5.36kr
Day's Low
5.05kr
Volume
1,981,361
Avg. Vol
5,006,665
52-wk High
16.70kr
52-wk Low
3.07kr

About

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company’s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. The Animal Health area focuses on developing cancer... (more)
No analyst recommendations are available for .

Overall

Beta: 1.50
Market Cap(Mil.): kr478.06
Shares Outstanding(Mil.): 176.41
Dividend: --
Yield (%): --

Financials

  OASM.ST Industry Sector
P/E (TTM): -- 29.89 32.67
EPS (TTM): -1.28 -- --
ROI: -44.58 14.89 14.48
ROE: -44.58 16.01 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates